We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stability Concerns Prompt Recall of Genzyme’s Kidney Transplant Drug
Stability Concerns Prompt Recall of Genzyme’s Kidney Transplant Drug
October 1, 2012
Genzyme is voluntarily recalling nine lots of its kidney transplant drug Thymoglobulin after one product lot failed a periodic stability test, the Sanofi subsidiary says.